About Novotech CRO
Novotech CRO is a company based in Sydney (Australia) founded in 2002 was acquired by TPG in August 2017. Novotech CRO has raised $255 million across 5 funding rounds from investors including TPG, Temasek and GIC. The company has 303 employees. Novotech CRO has completed 5 acquisitions, including Agilex Biolabs, CBR International and Clinical Network Services. Novotech CRO offers products and services including Clinical Operations, Patient Recruitment, and Data Management. Novotech CRO operates in a competitive market with competitors including Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
- Headquarter Sydney, Australia
- Employees 303
- Stage Unicorn
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website novotech-cro.com
- Social LinkedIn X Facebook YouTube
- Acquired by TPG (Aug 2017)
- Legal Name Novotech Clinical Research India Private Limited
- Date of Incorporation 14 Dec, 2007
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹44.62 Cr
FY 2023 · +24% YoY
- Net Profit₹2.70 Cr
FY 2023 · 6% margin
- EBITDA₹4.26 Cr
FY 2023 · 10% margin
- Total Equity Funding$255M (USD)
in 5 rounds
- InvestorsTPG
& 4 more
- Employee Count303
- Investments & AcquisitionsAgilex Biolabs
& 4 more
- Acquired byTPG
(Aug 2017)
Associated legal entities of Novotech CRO
Novotech CRO operates through Novotech Clinical Research India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Novotech Clinical Research India Private Limited CIN U85110KA2007PTC169840 | Active | 14 Dec 2007 | Bangalore, Karnataka | ₹44.6 Cr | 303 | 3 | View details |
Products & Services of Novotech CRO
Novotech CRO offers a comprehensive portfolio of products and services, including Clinical Operations, Patient Recruitment, and Data Management.
Manages clinical trial projects and operations for biotech firms.
Handles site selection and patient enrollment for clinical studies.
Provides statistical analysis and data handling for research trials.
Apps and channels of Novotech CRO
its YouTube channel Novotech, Australia (Sydney) has 81 subscribers and 8 videos.
Videos from Novotech CRO
The most watched videos on Novotech CRO's YouTube channel, Novotech, Australia (Sydney) (81 subscribers). Click a video to play it here.
More on Novotech, Australia (Sydney).
Funding Insights of Novotech CRO
Novotech CRO has successfully raised a total of $255M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $255M
- Total Rounds 5
- Investors Count 5
All 5 funding rounds of Novotech CRO with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | – | Seed | – | – | |
| Jan 2022 | $255M | Private Equity Round | $3B | – | – |
| Jan 2022 | $505M | Debt – Conventional | – | – | – |
| Feb 2021 | – | Private Equity Round | $2.3B | – | |
| Apr 2013 | – | Private Equity Round | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Jan 2022 | $3B | •••••••• |
| Feb 2021 | $2.3B | •••••••• |
Last known valuation $3B (Jan 2022). 5 investors in total: 5 institutional.
Investors in Novotech CRO
Novotech CRO has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include TPG, Temasek and GIC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Fund of funds focused on pre-seed and seed-stage companies | 1992 | tpg.com | Fort Worth, United States | |
An investment platform is provided for diverse sectors and geographies. | 1974 | temasek.com.sg | Singapore, Singapore | |
Sovereign wealth is managed and private equity investments are facilitated. | – | gic.com.sg | Singapore, Singapore | |
Sequoia Capital is engaged in venture capital investments. | 1972 | sequoiacap.com | - | |
Mercury Capital is engaged in private equity investments across industries. | 2010 | mercurycapital.com.au | Sydney, Australia |
Investor details for Novotech CRO
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Novotech Clinical Research India Private Limited (Novotech CRO)
Novotech Clinical Research India Private Limited is the primary company behind Novotech CRO. The board of Novotech Clinical Research India Private Limited currently have 3 directors; the longest-serving is John Russell Moller, appointed in 2017. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| John Russell Moller DIN 07827551 | Director | 30 Sep 2017 | 9 yrs | Novotech Clinical Research India Private Limited |
| Pandeshwara Ramakrishna Balachandra Chadaga DIN 09263220 | Director | 30 Nov 2021 | 4 yrs 10 mo | Novotech Clinical Research India Private Limited |
| Veronica Therese Holloway DIN 09652864 | Director | 19 Dec 2022 | 3 yrs 9 mo | Novotech Clinical Research India Private Limited |
People of Novotech CRO
88 people are tracked at Novotech CRO (38 in leadership, 5 in board & advisors, 45 in team); the tracked headcount is 303.
| Name | Role | Group |
|---|---|---|
| CEO & Board Member | Leadership | |
Angela Edwardson | Chief People Officer | Leadership |
Michael Stibilj | COO | Leadership |
Andrea Eleanor | Human Resource Business Partner | Leadership |
Ramesh Govindan | Director Regulatory Start-up Office | Leadership |
Narelle Bramich | Director Medical Writing | Leadership |
Scott Schliebner | Vice President And Global Head, Drug Development Consulting | Leadership |
Judith Ng-Cashin | Chief Medical Officer | Leadership |
Peter Blake | Director Compensation And Benefits | Leadership |
Aoife McDonnell | Director People Strategy | Leadership |
Flora Tseng | Associate Director, HR Business Partner | Leadership |
Hyun Kyoung Kim | Country Managing Director, S. Korea | Leadership |
Summer Chung | Senior Human Resources Business Partner | Leadership |
Mastan Shaik | Associate Director Global Pharmacometrics | Leadership |
Carolynne Darby | Associate Director Medical Advisor / Team Manager, Medical Directors | Leadership |
Kanhaiya Choudhary | Sr. Director And Country Head, India | Leadership |
Andreas Kroemer | Project Director | Leadership |
Veronica Clark | Associate Director Legal | Leadership |
Junru Tao | Head Of CRO Sales | Leadership |
Daleen Herman | Project Director | Leadership |
68 more people are available in the full profile.
Complete people profiles for Novotech CRO
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Novotech CRO
Figures of Novotech Clinical Research India Private Limited, the primary company behind Novotech CRO, for FY 2023. Revenue was ₹44.62 Cr (+24% year on year). Net profit was ₹2.70 Cr (6% margin). EBITDA was ₹4.26 Cr (10% margin). Revenue has grown at a compounded annual rate of +39% over three years and +53% over five years.
- ₹44.62 CrRevenue · FY 2023 · +24% YoY
- ₹2.70 CrNet profit · 6% margin
- ₹4.26 CrEBITDA · 10% margin
- ₹0.01 CrPaid-up capital
- 303Employees (provident fund records)
- +39%Revenue CAGR, 3 years
- +53%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Novotech Clinical Research India Private Limited are on its company page.
Detailed financial statements for Novotech CRO
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Novotech CRO
Novotech CRO has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Agilex Biolabs, CBR International and Clinical Network Services.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Bio-analytical testing services including LC-MS/MS and immunoassays are provided. | agilexbiolabs.com | Thebarton, Australia | 2009 | Sep 2026 | •••• | |
Provider of product development, clinical strategy, and regulatory consulting services for biopharma sector | cbrintl.com | Haarlem, Netherlands | 2001 | Jan 2023 | •••• | |
Full-service CRO operations are conducted for Phase I-IV clinical trials. | easthorn.com | Prague, Czech Republic | 2004 | Jan 2023 | •••• | |
Full-service CRO focused on clinical development in Oncology/Hematology, Infectious Disease, Critical Care and CNS | ncgs.com | Charleston, United States | 1984 | May 2022 | •••• | |
Early-stage clinical trials are managed by this Australian CRO. | clinical.net.au | Bengaluru, India | 1998 | Oct 2018 | •••• |
Complete acquisition details for Novotech CRO
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Novotech CRO
10 dated milestones of Novotech CRO across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Novotech CRO is founded.
- Funding First funding round.
- Exit Acquired by TPG.
- Acquisition Acquires Clinical Network Services.
- Milestone Reaches Unicorn status.
- Acquisition Acquires Ncgs.
- Acquisition Acquires EastHORN Clinical Services.
- Acquisition Acquires CBR International.
- Funding Latest funding round, Seed,.
- Acquisition Acquires Agilex Biolabs.
Competitors of Novotech CRO
Novotech CRO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| emmes.com | 1977 | United States | – | 195 | Outsourced contract research organization services are provided to clients. | |
| syneoshealth.com | 1984 | Raleigh, United States | – | 29,395 | CRO clinical development services are provided by Syneos Health. | |
| veristat.com | 1994 | Southborough, United States | – | 7 | Clinical trials and regulatory submissions are supported as a CRO. | |
| clinchoice.com | 1995 | Fort Washington, United States | $212M | 478 | CRO focused on data management, regulatory affairs and consulting services | |
| wcct.com | 1998 | Cypress, United States | $17M | 229 | Full-service CRO expertise in influenza and oncology research is offered. | |
| celgene.com | 1986 | Summit, United States | $45M | 4,891 | Therapies for cancer and inflammatory diseases are developed. | |
| hvivo.com | 1998 | London, United Kingdom | – | 133 | Provider of cell based assays, field trial, and molecular services for biopharma sector | |
| parexel.com | 1983 | Waltham, United States | – | – | Full-service clinical research organization services are provided globally by Parexel. |
Detailed competitors of Novotech CRO
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Novotech CRO
The website of Novotech CRO (novotech-cro.com) receives about 49.2K visits a month and ranks #897,361 among all websites worldwide, #1,077 in Biotechnology and Pharmaceuticals.
- Monthly visits49.2K
▲ 35.3% vs previous month
- Unique visitors15.8K
per month
- Global rank#897,361
among all websites
- Category rank#1,077
Health · Biotechnology and Pharmaceuticals
- Bounce rate39%
- Pages per visit1.6
- Average visit21 sec
- DevicesDesktop 38% · Mobile 62%
Websites whose visitors overlap most with Novotech CRO. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| precisionformedicine.com | 100% | 36.8K | #1,000,701 | View details | |
| lindushealth.com | 96% | 62.9K | #570,947 | View details | |
londontrials.com | londontrials.com | 94% | – | #601,753 | – |
| florencehc.com | 94% | 28.6K | #961,319 | View details | |
| syngeneintl.com | 94% | 94K | #525,515 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Novotech CRO
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Novotech Cro
Complete news archive for Novotech CRO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Novotech CRO
10 companies that operate in the same segment as Novotech CRO (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Novotech CRO
Novotech CRO was founded in 2002 and raised its 1st funding round 11 years after it was founded.
Novotech CRO is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Novotech CRO is a funded company, having raised a total of $255M across 5 funding rounds to date.
Novotech CRO has 303 employees.
The primary company behind Novotech CRO, Novotech Clinical Research India Private Limited, reported revenue of ₹44.62 Cr for FY 2023, up 24% year on year.
Provider of clinical research services across all trial phases and therapeutic areas. It offers services including medical and regulatory consulting, patient recruitment, site selection, early phase trials, clinical operations, project management, site management, biometrics, data management, virtual clinical trials, real-world data analysis, and laboratory services. It also provides specialized services for oncology, pharmacometrics, drug development consulting, GMO solutions, liver disease, infectious diseases, vaccines, and orphanrare diseases. It focuses on clinical and regulatory strategy to assist biotechnology companies in conducting early-phase clinical trials.
Novotech CRO's top competitors include Emmes, Syneos Health and ClinChoice.
Novotech CRO offers Clinical Operations, Patient Recruitment, and Data Management.
Novotech CRO has made 5 acquisitions, including Agilex Biolabs, CBR International, and Clinical Network Services.
Novotech CRO has 5 investors. Key investors include TPG, Temasek, GIC, Sequoia Capital, and Mercury Capital.
The valuation of Novotech CRO is $3B as of Jan 2022.
Novotech CRO operates through Novotech Clinical Research India Private Limited.